Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$7.06 - $23.63 $416,772 - $1.39 Million
-59,033 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$21.6 - $27.79 $2.26 Million - $2.91 Million
-104,676 Reduced 63.94%
59,033 $1.35 Million
Q4 2021

Feb 10, 2022

BUY
$23.0 - $29.01 $3.23 Million - $4.08 Million
140,479 Added 604.73%
163,709 $4.52 Million
Q3 2021

Nov 12, 2021

SELL
$25.04 - $30.06 $1.97 Million - $2.36 Million
-78,599 Reduced 77.19%
23,230 $647,000
Q2 2021

Aug 12, 2021

SELL
$27.43 - $32.7 $2.81 Million - $3.35 Million
-102,387 Reduced 50.14%
101,829 $2.99 Million
Q1 2021

May 17, 2021

SELL
$21.37 - $34.38 $1.25 Million - $2.01 Million
-58,583 Reduced 22.29%
204,216 $6.48 Million
Q4 2020

Feb 12, 2021

BUY
$15.31 - $21.12 $4.02 Million - $5.55 Million
262,799 New
262,799 $5.47 Million
Q3 2020

Nov 13, 2020

SELL
$14.88 - $20.13 $4.71 Million - $6.38 Million
-316,758 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$13.31 - $20.51 $8.66 Million - $13.3 Million
-650,494 Reduced 67.25%
316,758 $5.79 Million
Q1 2020

May 13, 2020

BUY
$12.98 - $30.25 $8.94 Million - $20.8 Million
688,671 Added 247.21%
967,252 $15 Million
Q3 2019

Nov 12, 2019

BUY
$20.88 - $25.66 $4.97 Million - $6.11 Million
238,046 Added 587.26%
278,581 $6.09 Million
Q2 2019

Aug 12, 2019

SELL
$20.52 - $26.45 $3.47 Million - $4.47 Million
-168,889 Reduced 80.64%
40,535 $1.02 Million
Q1 2019

May 10, 2019

SELL
$20.23 - $26.29 $4.63 Million - $6.02 Million
-228,957 Reduced 52.23%
209,424 $5.17 Million
Q4 2018

Feb 13, 2019

BUY
$17.64 - $28.32 $5.64 Million - $9.05 Million
319,497 Added 268.75%
438,381 $8.1 Million
Q3 2018

Nov 09, 2018

BUY
$20.64 - $25.67 $2.45 Million - $3.05 Million
118,884 New
118,884 $3.05 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.97B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.